Adjuvant treatment in early, advanced and recurrent ovarian cancer
ESGO eAcademy. Presenters F. 06/16/18; 219382
Topic: Management
Faculty / Presenters

REGULAR CONTENT
Login now to access Regular content available to all registered users.
Click here to create a free account.
Access to Premium content is currently a membership benefit.
Click here to join ESGO or renew your membership.
You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
Click here to create a free account.
Access to Premium content is currently a membership benefit.
Click here to join ESGO or renew your membership.
You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}